Compare PPG Industries, Inc. (PPG) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PPG Industries, Inc. vs Tango Therapeutics Inc. — how do they compare? PPG Industries, Inc. trades at $104.87 (market cap $23.31B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.74B). The key difference: PPG Industries, Inc. is far larger — about 6.2× Tango Therapeutics Inc.'s market cap, and PPG Industries, Inc. pays a 2.82% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold PPG Industries, Inc. for 68 Days and Tango Therapeutics Inc. for 0 Days on average.
| PPG | TNGX | |
|---|---|---|
Market Cap | $23.31B | $3.74B |
Volume | 1,812,724 | 3,438,781 |
Sector | Basic Materials | Health |
52-Week High | $131.56 | $32.90 |
52-Week Low | $94.34 | $7.50 |
Typical Hold Time | 68 Days | 0 Days |
Enterprise Value | $29.18B | $2.76B |
Dividend Yield | 2.82% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PPG Industries trades at $104.55, up 0.81% on the day, with a bearish technical signal from moving averages and oscillators. The company reported mixed Q2 2026 earnings, missing EPS estimates but showing 7% revenue growth. Fundamentals are solid with a P/E of 15, net income margin of 9.57%, and strong cash flow from operations of $1.94B in 2025. Recent news highlights innovation initiatives and leadership appointments aimed at driving growth.
The outlook is cautiously optimistic with a consensus price target of $130.50, implying 25% upside, supported by 55% analyst buy ratings. Key risks include margin pressures in the Automotive Refinish segment and macroeconomic headwinds in Europe. The stock offers value at current levels but requires monitoring of Q3 earnings on Oct 27 for confirmation of growth trajectory.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
